Veterinary Point of Care Diagnostics Market Report Scope & Overview:

The Veterinary Point of Care Diagnostics Market was valued at USD 2.42 Billion in 2025 and is expected to reach USD 6.28 Billion by 2035, growing at a CAGR of 10.03% from 2026 to 2035.

The Veterinary Point of Care Diagnostics market is growing due to the high levels of pet humanization in developed economies, the need for fast surveillance of diseases among livestock in emerging markets, and ongoing technology miniaturization. Since point of care diagnostics provide results immediately and facilitate treatment decisions, they have been widely used in veterinary hospitals, and there has been no need for independent laboratory tests and shorter turnaround time such that the veterinarian can tend to his patient quickly. Molecular technology is developing the most rapidly due to advances in isothermal amplification and CRISPR technologies, which have decreased the turnaround time to minutes, whereas antimicrobial stewardship guidelines are impacting device selection.

IDEXX launched IDEXX Cancer Dx in June 2025, a fifteen-dollar canine lymphoma panel delivering results within two to three days, expanding the company's point-of-care oncology testing capability for veterinary clinics seeking faster cancer diagnosis and treatment planning for companion animals.

Market Size and Forecast

• Market Size in 2026E: USD 2.66 Billion

• Market Size by 2035: USD 6.28 Billion

• CAGR: 10.03% from 2026 to 2035

• Fastest Growing Region: Asia Pacific

• Largest Region: North America

To Get more information On Veterinary Point Of Care Diagnostics Market - Request Free Sample Report

Veterinary Point of Care Diagnostics Market Trends

• Strong pet humanization in mature economies continues driving demand for advanced near-patient diagnostic testing.

• Isothermal amplification and CRISPR innovations are cutting molecular diagnostic turn-around times to minutes.

• Antimicrobial-stewardship rules are increasingly influencing equipment adoption as veterinarians confirm infection type before treatment.

• Rapid livestock disease surveillance needs in developing regions continue expanding point-of-care testing beyond companion animals.

• Portable analyzers and immunodiagnostics continue enhancing the accessibility and accuracy of decentralized veterinary testing.

The United States Veterinary Point of Care Diagnostics Market Outlook

The United States Veterinary Point of Care Diagnostics Market was valued at USD 1.13 Billion in 2025 and is expected to reach USD 2.73 Billion by 2035, growing at a CAGR of 9.20% from 2026 to 2035.

The United States maintained a leading position in North American veterinary point of care diagnostics demand, predominantly fueled by a surge in spending on pet-related products and services, an expanding number of pet owners, and continued technological advancement. The rise in companion animal population continued driving demand for veterinary healthcare services and increasing overall pet spending, keeping the country among the most commercially significant national markets for this technology throughout the year.

Antech Diagnostics, headquartered in Fountain Valley, California and part of the Mars Petcare network, continued expanding its point-of-care diagnostic instrument placement across American veterinary clinics and hospitals, reinforcing its position alongside IDEXX as one of the two dominant reference and point-of-care diagnostic providers serving the United States veterinary market.

Veterinary Point of Care Diagnostics Market Segmentation Analysis

• By Product, the consumables reagents kits segment held approximately 60.00% share in veterinary point of care diagnostics market in 2025, while the instruments analyzers segment is the fastest growing.

• By Animal Type, the companion animals segment held approximately 58.60% share in veterinary point of care diagnostics market in 2025, while the livestock animals segment is the fastest growing.

• By Technology, the immunodiagnostics segment held the largest share in veterinary point of care diagnostics market in 2025, while the molecular diagnostics segment is the fastest growing, with a CAGR of approximately 12.13%.

• By Testing Category, the infectious disease testing segment held the largest share in veterinary point of care diagnostics market in 2025, while the oncology testing segment is the fastest growing.

By Product, consumables reagents kits led the veterinary point of care diagnostics market, instruments analyzers grew fastest

The consumables reagents kits segment dominated the product category in 2025, holding approximately 60.00% of total revenue, driven by frequent replacement and wide applicability across multiple diagnostic procedures, from infectious disease screening to hematology and biochemistry tests. That recurring, consumable-driven revenue model continues keeping this product category firmly at the top of the broader product segmentation across nearly every veterinary point of care diagnostic workflow.

The instruments analyzers segment is projected to grow at the fastest CAGR during the forecast period, driven by sustained technological miniaturization that continues making advanced diagnostic platforms accessible to smaller veterinary clinics and mobile practice settings. Rising demand for compact, easy-to-use analyzers capable of delivering laboratory-grade results at the point of care continues pushing this product category's growth rate ahead of the broader product segmentation.

By Animal Type, companion animals led the veterinary point of care diagnostics market, livestock animals grew fastest

The companion animals segment held the largest animal type share in 2025, at approximately 58.60%, anchored by strong pet humanization trends in mature economies that continue driving pet owners toward more comprehensive, human-grade veterinary care. That sustained companion animal healthcare spending keeps this segment firmly at the center of overall veterinary point of care diagnostics demand across nearly every major regional market.

The livestock animals segment is projected to grow at the fastest CAGR during the forecast period, driven by rapid livestock disease surveillance needs in developing regions where government focus on food security and export compliance continues elevating diagnostic testing requirements. Rising government investment in livestock disease monitoring infrastructure continues pushing this animal type category's growth rate ahead of the broader animal type segmentation.

By Technology, immunodiagnostics led the veterinary point of care diagnostics market, molecular diagnostics grew fastest

The largest market share was occupied by the segment of immunodiagnostics technology because this technology allows the rapid and precise detection of infectious and chronic diseases in companion and farm animals at an affordable price. Thus, it is considered the most used technology for point-of-care tests of veterinary medicine.

The molecular diagnostics segment is projected to grow at the fastest CAGR of approximately 12.13% during the forecast period, outpacing all other technology segments due to rapid, high-sensitivity pathogen detection made possible by isothermal amplification and CRISPR innovations. That technological leap in turn-around time, cutting results delivery to minutes, continues pushing molecular diagnostics adoption well ahead of the broader technology segmentation.

By Testing Category, infectious disease testing led the veterinary point of care diagnostics market, oncology testing grew fastest

The infectious disease testing segment held the largest testing category share in 2025, as these diseases continue posing significant risk to both companion and livestock animal populations, leading to high morbidity and driving sustained veterinary testing demand. That persistent disease burden keeps infectious disease testing firmly at the center of overall veterinary point of care diagnostics demand across nearly every major market.

The oncology testing segment is projected to grow at the fastest CAGR during the forecast period, driven by rising cancer diagnosis rates in aging companion animal populations and growing pet owner willingness to pursue advanced diagnostic and treatment pathways. New point-of-care cancer panels delivering results within days rather than weeks continue pushing this testing category's growth rate ahead of the broader testing category segmentation.

Regional Analysis

North America Veterinary Point of Care Diagnostics Market Insights

North America held the largest share of the global veterinary point of care diagnostics market in 2025, at approximately 47.93%, supported by highly developed veterinary healthcare infrastructure, significant increase in rapid diagnostics use, and the prominent presence of leading diagnostic companies. Strong pet humanization trends and high per-capita pet expenditure continued reinforcing this leadership position throughout the year.

The United States was responsible for about 85.60% of the revenue generated in the region because it had the major veterinary diagnostic players along with comprehensive companion animal healthcare systems. Canada added to the revenue in the region through its own growing adoption of veterinary healthcare facilities, ensuring that North America remained the market leader over all other regions.

Get Customized Report as per Your Business Requirement - Enquiry Now

Europe Veterinary Point of Care Diagnostics Market Insights

Europe held a substantial share of the global veterinary point of care diagnostics market in 2025, supported by strong regulatory frameworks, growing focus on animal welfare, and expanding veterinary research initiatives across the continent. With a market share of about 27.30%, Germany benefited from being a hub of veterinary diagnostic equipment manufacturing and companion animal healthcare facilities.

Other countries following the same pattern included France, the United Kingdom, and the Netherlands, owing to the increased regulation of animal welfare and investment in veterinary research. Continued emphasis on preventive veterinary care is expected to keep supporting steady European demand through the remainder of the forecast period.

Asia Pacific Veterinary Point of Care Diagnostics Market Insights

Asia Pacific was the fastest-growing region in the global Veterinary point of care diagnostics market, with a CAGR near 11.34% through the forecast period, driven by rising pet ownership, expanding veterinary infrastructure, and government focus on livestock disease surveillance. India in particular is expected to register the highest country-level CAGR through the forecast period, reflecting rapidly expanding veterinary healthcare access.

China accounted for roughly 36.10% of regional revenue, supported by expanding domestic veterinary infrastructure and rising companion animal ownership. Japan and South Korea contributed significant additional regional demand through their own advanced veterinary healthcare adoption, reinforcing Asia Pacific's position as the clear growth leader in this market.

MEA & Latin America Veterinary Point of Care Diagnostics Market Insights

Middle East & Africa had consistent gains in point of care veterinary diagnostics adoption rate in 2025 due to increasing efforts towards livestock disease surveillance funding and increase in the number of companion animals in the gulf countries. United Arab Emirates made up about 26.40% of total regional revenue due to the country's strategy on modern veterinary healthcare system development.

Latin America expanded at a comparable pace, led by Brazil at roughly 37.50% of regional revenue, where growing livestock production and companion animal healthcare investment continued to support category growth. Mexico and Argentina followed a similar trajectory as regional veterinary healthcare infrastructure expanded further through the remainder of the forecast period.

Growth Drivers: Pet humanization and molecular diagnostic innovation

Strong pet humanization in mature economies continues to be the central force behind veterinary point of care diagnostics market growth, as pet owners increasingly seek human-grade diagnostic and treatment options for their companion animals. Rapid livestock disease surveillance needs in developing regions continue reinforcing this growth trajectory, as governments prioritize food security and export compliance through expanded animal health monitoring infrastructure.

Sustained technological miniaturization continues fueling demand for near-patient testing, as isothermal amplification and CRISPR innovations cut molecular diagnostic turn-around times to minutes rather than days. Antimicrobial-stewardship rules increasingly influencing equipment adoption, as veterinarians seek to confirm bacterial versus viral infections before prescribing treatment, continue reinforcing structural demand growth across nearly every major veterinary diagnostic category worldwide.

Restraints: High equipment costs and limited rural veterinary infrastructure

The substantial capital investment required to acquire advanced point of care diagnostic instruments continues to restrict adoption among smaller veterinary practices and clinics in rural or underserved areas working with constrained budgets. That cost barrier continues to concentrate the most advanced diagnostic capability within larger veterinary hospital systems and specialty referral centers.

Limited veterinary healthcare infrastructure in developing regions continues restricting access to advanced point of care diagnostics, particularly for livestock disease surveillance applications where testing coverage remains genuinely inconsistent. That infrastructure gap continues requiring sustained government and institutional investment alongside pure technology development to achieve meaningful improvement in diagnostic testing access.

Opportunities: Livestock surveillance expansion and oncology panel innovation

Growing government focus on livestock disease surveillance in developing regions presents substantial opportunity for diagnostic manufacturers positioned to serve this expanding application category beyond companion animal testing. Manufacturers capable of delivering rugged, field-deployable diagnostic platforms suited to livestock and farm settings stand to capture a growing share of demand as government surveillance programs continue expanding.

Continued innovation in point-of-care oncology testing presents a further significant growth avenue, as new cancer panels delivering results within days rather than weeks continue expanding diagnostic and treatment options for aging companion animal populations. Manufacturers capable of delivering affordable, rapid oncology testing stand to capture meaningful new revenue streams as pet owner willingness to pursue advanced cancer diagnostics continues growing through 2035.

Recent Developments:

• 2025: Zoetis continued expanding its point-of-care diagnostic platform portfolio, strengthening its position serving veterinary clinics requiring rapid infectious disease and wellness testing capability for companion animals.

• 2025: Heska Corporation continued advancing its in-house diagnostic instrument lineup, targeting veterinary practices seeking comprehensive hematology, chemistry, and immunodiagnostic testing capability within a single platform.

• 2024: Virbac continued expanding its rapid diagnostic test kit portfolio for companion and livestock animal infectious disease screening, strengthening its position across European and emerging veterinary markets.

Veterinary Point of Care Diagnostics Market key players are:

• IDEXX Laboratories, Inc.

• Zoetis Inc.

• Virbac S.A.

• Heska Corporation

• Thermo Fisher Scientific Inc.

• Neogen Corporation

• Mindray Medical International Limited

• Esaote S.p.A.

• FUJIFILM Corporation

• Woodley Equipment Company Ltd.

• Antech Diagnostics, Inc.

• Randox Laboratories Ltd.

• Boehringer Ingelheim Animal Health

• ELITechGroup

• Chembio Diagnostics, Inc.

• bioMérieux SA

• Alfa Scientific Designs, Inc.

• Scil Animal Care Company GmbH

• VCA Inc.

• IDvet

Veterinary Point of Care Diagnostics Market Report Scope :